HK1104460A1 - Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases - Google Patents

Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases

Info

Publication number
HK1104460A1
HK1104460A1 HK07109654.1A HK07109654A HK1104460A1 HK 1104460 A1 HK1104460 A1 HK 1104460A1 HK 07109654 A HK07109654 A HK 07109654A HK 1104460 A1 HK1104460 A1 HK 1104460A1
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
medicament
manufacture
treatment
infectious diseases
Prior art date
Application number
HK07109654.1A
Other languages
English (en)
Inventor
Kjaeldgaard Giwercman Birgit
Original Assignee
Bkg Pharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bkg Pharma Aps filed Critical Bkg Pharma Aps
Publication of HK1104460A1 publication Critical patent/HK1104460A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HK07109654.1A 2004-04-30 2007-09-05 Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases HK1104460A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400680 2004-04-30
DKPA200401716 2004-11-08
PCT/DK2005/000294 WO2005105145A1 (fr) 2004-04-30 2005-04-29 Traitement de maladies infectieuses

Publications (1)

Publication Number Publication Date
HK1104460A1 true HK1104460A1 (en) 2008-01-18

Family

ID=34965444

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109654.1A HK1104460A1 (en) 2004-04-30 2007-09-05 Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases

Country Status (13)

Country Link
US (1) US20080318970A1 (fr)
EP (2) EP2260870A3 (fr)
JP (2) JP5026255B2 (fr)
CN (1) CN1976723B (fr)
AU (1) AU2005237208B2 (fr)
CA (1) CA2564684C (fr)
DK (1) DK1744781T3 (fr)
EA (1) EA016803B1 (fr)
ES (1) ES2390226T3 (fr)
HK (1) HK1104460A1 (fr)
MX (1) MXPA06012566A (fr)
NO (1) NO20065469L (fr)
WO (1) WO2005105145A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080398A1 (fr) * 2007-01-05 2008-07-10 Bkg Pharma Aps Agents anti-infectieux tels que des dérivés de phénothiazine et de thioxanthène pour traiter les maladies infectieuses
EP2246349A1 (fr) * 2009-04-20 2010-11-03 BKG Pharma ApS Traitement de maladies infectieuses
EP2739285B9 (fr) * 2011-08-02 2019-09-04 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibition sélective de la protéase malt1 par des dérivés de phénothiazine
EP2758403B1 (fr) 2011-09-21 2016-04-27 Inception Orion, Inc. Composés tricycliques utiles comme agents neurogènes et neuroprotecteurs
EP2760820A4 (fr) * 2011-09-29 2015-04-29 Univ Emory Analogues de sphingosine, compositions et procédés afférents
RU2663289C2 (ru) * 2012-11-26 2018-08-03 Юниверсити Оф Кейптаун Производные фенотиазина и их применение против туберкулеза
KR101798176B1 (ko) * 2014-12-16 2017-11-15 주식회사 엠디헬스케어 세균 유래의 나노소포체를 이용한 세균성 감염질환 원인균 동정방법
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
MX2018016339A (es) 2016-06-23 2019-09-04 Bioimics Ab Compuestos heterociclicos antiinfecciosos y sus usos.
WO2018070874A1 (fr) * 2016-10-12 2018-04-19 Rijksuniversiteit Groningen Moyens et procédés pour réduire ou éviter la résistance aux antibiotiques et la propagation de virulence chez des pathogènes humains
EP3958975A1 (fr) * 2019-04-24 2022-03-02 Københavns Universitet Nouvelle classe d'antibiotiques ayant de faibles concentrations minimales inhibitrices (cmi) à l'égard de différentes souches de bactéries
CN112353805A (zh) * 2020-11-17 2021-02-12 北京化工大学 氟哌噻吨在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE578983A (fr) 1958-05-29
DE1518325B1 (de) 1960-03-07 1970-08-27 Smith Kline French Lab Basisch substituierte Trifluormethylxanthene und deren nicht toxische Saeureadditionssalze und Verfahren zu deren Herstellung
HU190078B (en) * 1983-03-25 1986-08-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing new antibacterial pharmaceutical composition and/or food-premix
NZ228748A (en) * 1988-04-20 1991-07-26 Merrell Dow Pharma Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6989396B2 (en) * 2001-04-12 2006-01-24 The Board Of Trustees Of The University Of Illinois Tropane alkaloid multidrug resistance inhibitors from Erythroxylum pervillei and use of the same
WO2002089810A1 (fr) * 2001-05-07 2002-11-14 United States Army Medical Research And Materiel Command Agents de chimiosensibilisation contre plasmodium falciparum resistant a la chloroquine et leurs procedes d'utilisation
JP4570357B2 (ja) 2001-07-06 2010-10-27 ライフサイクル ファーマ エー／エス 制御された凝集
WO2003062388A2 (fr) * 2002-01-16 2003-07-31 The Regents Of The University Of California Inhibition de fonction arn
AU2003205543A1 (en) 2003-01-14 2004-08-10 Lifecycle Pharma A/S Dry dispersions
US8623864B2 (en) * 2003-11-13 2014-01-07 Noa Sic Aps Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance

Also Published As

Publication number Publication date
MXPA06012566A (es) 2007-05-09
US20080318970A1 (en) 2008-12-25
JP2007535510A (ja) 2007-12-06
JP2012082219A (ja) 2012-04-26
EA016803B1 (ru) 2012-07-30
WO2005105145A1 (fr) 2005-11-10
DK1744781T3 (da) 2012-10-15
ES2390226T3 (es) 2012-11-07
EP2260870A3 (fr) 2012-12-26
JP5026255B2 (ja) 2012-09-12
NO20065469L (no) 2007-01-24
AU2005237208A1 (en) 2005-11-10
EP1744781B1 (fr) 2012-07-04
CN1976723B (zh) 2010-12-29
EA200601889A1 (ru) 2007-06-29
CA2564684C (fr) 2010-10-26
EP2260870A2 (fr) 2010-12-15
CN1976723A (zh) 2007-06-06
AU2005237208B2 (en) 2009-12-03
CA2564684A1 (fr) 2005-11-10
EP1744781A1 (fr) 2007-01-24

Similar Documents

Publication Publication Date Title
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
TWI369210B (en) Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
IL178815A0 (en) The treatment of respiratory disease
EP1789034A4 (fr) Composes presentant une structure diphenylique destines au traitement de maladies immunitaires
IL184124A0 (en) Medicaments for the treatment or prevention of fibrotic diseases
EP1962869A4 (fr) Traitement de maladies respiratoires
GB0410399D0 (en) The treatment of respiratory disease
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
GB0523961D0 (en) The treatment of ophthalmic diseases
PL1670482T5 (pl) Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
HU0500145D0 (en) Composition for the treatment of oral diseases
PL1714647T3 (pl) Zastosowanie agomelatyny do wytwarzania leku do leczenia zaburzeń dwubiegunowych
HK1119064A1 (en) Use of azithromycin for the production of a medicament for treatment of ocular infections
GB0523964D0 (en) The treatment of ophthalmic diseases
EP1864671A4 (fr) Utilisation d acide chlorhydrique pour la fabrication d un medicament pour le traitement de l'hypertension
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
ZA200606780B (en) Compounds for the treatment of diseases
IL191208A (en) Use of phenofibrate or its derivative for the preparation of a drug for the treatment of diabetic retinopathy
IL186916A0 (en) Use of insp052 polypeptide for the preparation of a medicament for treating diseases
GB0425073D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160429